Abstract
Aging is responsible for homeostatic dysregulation and the primary risk for neurodegenerative diseases. The main signaling pathways may regulate inflammatory-related disorders and neurodegeneration include genomic instability, cell senescence, and mitochondria dysfunction. The use of high-throughput technologies has emerged as a powerful approach to the rapid discovery of many candidate biomarkers for age-related diseases. Various types of molecules, such as nucleic acids, proteins, or metabolites, can serve as soluble factors in clinical practice with deviations in their normal biological levels being an indication of an underlying disease state. The development of multifactorial biomarkers based on models involving molecular alterations in complex disorders may also provide specific challenges for translating biological findings and targeted diagnostic tools. As diseases are often regulated by a multiset of markers that coordinate and interact each other in a complex signaling network to maintain holistic processes within a cell, potent network-based approaches to data-driven biomarker identification are required. System-based biomarker discovery pipelines can offer an extraordinary adjustment opportunity for data heterogeneity and limitation, whereas integrated analysis of distinct networks clusters can provide important information for the early detection of intracellular pathogenic processes as well as for monitoring the response to treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Vega S, Abian O, Velazquez-Campoy A (2019) Handling complexity in biological interactions. Journal of Thermal Analysis and Calorimetry 138:3229–3248
Srinivasan K, Friedman BA, Larson JL, Lauffer BE, Goldstein LD et al (2016) Untangling the brain’s neuroinflammatory and neurodegenerative transcriptional responses. Nat Commun 7:11295
Kany S, Vollrath JT, Relja B (2019) Cytokines in Inflammatory Disease. Int J Mol Sci. 20:6008
Fu H, Hardy J, Duff KE (2018) Selective vulnerability in neurodegenerative diseases. Nat Neurosci 21:1350–1358
Yu-Wai-Man P (2016) Genetic manipulation for inherited neurodegenerative diseases: myth or reality? Br J Ophthalmol 10:1322–1331
Krokidis MG, Vlamos P (2018) Transcriptomics in amyotrophic lateral sclerosis. Front Biosci (Elite Ed) 10:103–121
Cioffi F, Ibrahim Adam RH, Broersen K (2019) Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer’s Disease. J Alzheimers Dis 72: 981–1017
Liao Y, Dong Y, Cheng J (2017) The Function of the Mitochondrial Calcium Uniporter in Neurodegenerative Disorders. Int J Mol Sci 18:248
Aguilera G, Colín-González AL, Rangel-López E, Chavarría A, Santamaría A (2018) Redox signaling, neuroinflammation, and neurodegeneration. Antioxid Redox Signal 28(18):1626–1651
Cai Y, An SS, Kim S (2015) Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders Clin Interv Aging 10:1163–1172
Murphy MP and LeVine III H (2010) Alzheimer’s Disease and the β-Amyloid Peptide J Alzheimers Dis. 19: 311
Prentice H, Modi JR, Wu J-Y (2015) Mechanisms of Neuronal Protection against Excitotoxicity, Endoplasmic Reticulum Stress, and Mitochondrial Dysfunction in Stroke and Neurodegenerative Diseases. Oxid Med Cell Longev. 2015: 964518
Wang R and Reddy PH (2017) Role of glutamate and NMDA receptors in Alzheimer’s disease. J Alzheimers Dis 57: 1041–1048
Denis PA (2013) Alzheimer's disease: a gas model. The NADPH oxidase-Nitric Oxide system as an antibubble biomachinery. Med Hypotheses 81:976–987
Garrido C, Galluzzi L, Brunet M, Puig PE, Didelot C, Kroemer G (2006) Mechanisms of cytochrome c release from mitochondria. Cell Death Differ 13:1423–1433
Sultana R, Perluigi M, Butterfield DA (2013) Lipid Peroxidation Triggers Neurodegeneration: A Redox Proteomics View into the Alzheimer Disease Brain. Free Radic Biol Med 62:157–169
Mao P, Reddy PH (2011) Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: Implications for early intervention and therapeutics Biochim Biophys Acta. 1812:1359–1370
Mórocz M, Kálmán J, Juhász A, Sinkó I, McGlynn AP, Downes CS, Janka Z, Raskó I (2002) Elevated levels of oxidative DNA damage in lymphocytes from patients with Alzheimer's disease. Neurobiol Aging 23:47–53
Bergman M, Salman H, Beloosesky Y, Djaldetti M, Bessler H (2002) Are peripheral blood cells from patients with Alzheimer disease more sensitive to apoptotic stimuli? Alzheimer Dis Assoc Disord 16:156–60
David H (2009) Small Dysregulation of calcium homeostasis in Alzheimer's disease. Neurochem Res 34:1824–1829
Mufson EJ, Counts SE, Perez SE, Ginsberg SD (2008) Cholinergic system during the progression of Alzheimer's disease: therapeutic implications. Expert Rev Neurother 8:1703–1718
Tayebati SK, Amenta F, Amici S, El-Assouad D, Gallai V, Ricci A, Parnetti L (2001) Peripheral blood lymphocytes muscarinic cholinergic receptor subtypes in Alzheimer's disease: a marker of cholinergic dysfunction? J Neuroimmunol 121:126–131
Tan E-K, Chao Y-X, West A, Chan L-L, Poewe W, Jankovic J (2020) Parkinson disease and the immune system - associations, mechanisms and therapeutics. Nat Rev Neurol 16:303–318
Musella A, Gentile A, Rizzo FR, De Vito F, Fresegna D, Bullitta S et al (2018) Interplay between age and neuroinflammation in multiple sclerosis: Effects on motor and cognitive functions. Front Aging Neurosci 10:238
Hickman S, Izzy S, Sen P, Morsett L, El Khoury J (2018) Microglia in neurodegeneration. Nat Neurosci 21:1359–1369
Agrawal M and Biswas A (2015) Molecular diagnostics of neurodegenerative disorders. Front Mol Biosci 2: 54
Strimbu K and Tavel JA (2010) What are Biomarkers? Curr Opin HIV AIDS. 5:463–466
Galasko D (2015) Expanding the Repertoire of Biomarkers for Alzheimer’s Disease: Targeted and Non-targeted Approaches. Front Neurol. 6:256
Sobsey CA, Ibrahim S, Richard VR, Gaspar V, Mitsa G, Lacasse V, Zahedi RP, Batist G, Borchers CH (2020) Targeted and Untargeted Proteomics Approaches in Biomarker Development. Proteomics 20:e1900029
Park ST and Kim J (2016) Trends in Next-Generation Sequencing and a New Era for Whole Genome Sequencing. Int Neurourol J 20:S76–83
Trevino V, Falciani F, Barrera-Saldaña HA (2007) DNA microarrays: a powerful genomic tool for biomedical and clinical research. Mol Med 13:527–541
Ballester LY, Luthra R, Kanagal-Shamanna R, Singh RR (2016) Advances in clinical next-generation sequencing: target enrichment and sequencing technologies. Expert Rev Mol Diagn 16:357–372
Rouzier C, Chaussenot A, Serre V, Fragaki K, Bannwarth S, Ait-El-Mkadem S et al (2014). Quantitative multiplex PCR of short fluorescent fragments for the detection of large intragenic POLG rearrangements in a large French cohort. Eur J Hum Genet 22:542–550
Jeuken J, Cornelissen S, Boots-Sprenger S, Gijsen S, Wesseling P (2006) Multiplex Ligation-Dependent Probe AmplificationA Diagnostic Tool for Simultaneous Identification of Different Genetic Markers in Glial Tumors. J Mol Diagn 8:433–443
Guerreiro R, Brás J, Hardy J and Singleton A (2014) Next generation sequencing techniques in neurological diseases: redefining clinical and molecular associations. Hum Mol Genet 23:R47–R53
Salk JJ, Schmitt MW, Loeb LA (2018) Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations. Nat Rev Genet 19:269–285
Snider J, Kotlyar M, Saraon P, Yao Z, Jurisica I, Stagljar I (2015) Fundamentals of protein interaction network mapping. Mol Syst Biol. 11:848
Olshina MA, Sharon M (2016) Mass Spectrometry: A Technique of Many Faces. Q Rev Biophys 49:e18
Ding Z and Kihara D (2018) Computational Methods for Predicting Protein-Protein Interactions Using Various Protein Features. Curr Protoc Protein Sci 93:e62
Wang Y-C, Chen S-L, Deng N-Y, Wang Y (2016) Computational probing protein-protein interactions targeting small molecules. Bioinformatics 32:226–234
Gorrochategui E, Jaumot J, Lacorte S, Tauler R (2016) Data analysis strategies for targeted and untargeted LC-MS metabolomic studies: Overview and workflow. Trends in Analytical Chemistry 82:425–442
Maudsley S, Chadwick W, Wang L, Zhou Y, Martin B, Park S-S (2011) Bioinformatic Approaches to Metabolic Pathways Analysis. Methods Mol Biol 756:99–130
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this paper
Cite this paper
Krokidis, M.G. (2021). Biomarker-Driven Analysis Using High-Throughput Approaches in Neuroinflammation and Neurodegenerative Diseases. In: Vlamos, P. (eds) GeNeDis 2020. Advances in Experimental Medicine and Biology, vol 1339. Springer, Cham. https://doi.org/10.1007/978-3-030-78787-5_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-78787-5_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-78786-8
Online ISBN: 978-3-030-78787-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)